Ramanadham S, Lyness W H
Neuropharmacology. 1982 Jun;21(6):569-73. doi: 10.1016/0028-3908(82)90049-1.
The uricosuric agent, probenecid, when administered prior to systemic administration of pentobarbital led to a decreased latency, to loss of righting reflex and to a potentiation of the duration of hypnosis. This potentiation was dose-related and doses of probenecid below 50 mg/kg (i.p.) were without effect. Pretreatment of rats with sulfinpyrazone, another uricosuric agent, yielded similar results. Pretreatment of animals with probenecid shortened the latency to onset of hypnosis induced by halothane (i.p.) and increased the duration of loss of righting reflex, 3-fold. Both sulfinpyrazone and probenecid, administered prior to 1.0% inhalation halothane exposure, shortened the latency to onset of hypnosis in doses as small as 10 mg/kg, much less than the doses required to affect significantly pentobarbital-induced hypnosis. The results, as yet, do not indicate a plausible mechanism of action, but do expose a potentially useful drug interaction which may be of clinical use.
尿酸排泄促进剂丙磺舒在戊巴比妥全身给药前给药,会导致翻正反射消失的潜伏期缩短以及催眠持续时间延长。这种增强作用与剂量相关,丙磺舒剂量低于50mg/kg(腹腔注射)时无作用。用另一种尿酸排泄促进剂磺吡酮对大鼠进行预处理,也得到了类似结果。用丙磺舒对动物进行预处理可缩短氟烷(腹腔注射)诱导催眠的起始潜伏期,并使翻正反射消失的持续时间增加3倍。在吸入1.0%氟烷前给予磺吡酮和丙磺舒,剂量低至10mg/kg时均可缩短催眠起始潜伏期,远低于显著影响戊巴比妥诱导催眠所需的剂量。目前,这些结果尚未表明其合理的作用机制,但确实揭示了一种可能具有临床用途的潜在有用药物相互作用。